PKCδ protects human breast tumor MCF-7 cells against tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis

Journal of Cellular Biochemistry

Volumn 96, Issue 3, 2005, Pages 522-532

  Zhang, Jindan ^a   Liu, Ning ^a   Zhang, Jingchun ^a   Liu, Shilian ^a   Liu, Yanxin ^a   Zheng, Dexian ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Apoptosis; Caspase; MCF 7; NF B; PKC ; Trail

Indexed keywords

CASPASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE C DELTA; RECOMBINANT PROTEIN; RECOMBINANT TRAIL PROTEIN; ROTTLERIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; ACETOPHENONE DERIVATIVE; APOPTOSIS REGULATORY PROTEIN; BENZOPYRAN DERIVATIVE; CASP9 PROTEIN, HUMAN; CASPASE 9; ENZYME INHIBITOR; MEMBRANE PROTEIN; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER THERAPY; CELL PROTECTION; CELL STRAIN MCF 7; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; RNA INTERFERENCE; SENSITIZATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; BREAST TUMOR; DRUG ANTAGONISM; ENZYME ACTIVATION; FEMALE; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; TUMOR CELL LINE;

MINK CELL FOCUS-FORMING VIRUS;

ACETOPHENONES; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BENZOPYRANS; BREAST NEOPLASMS; CASPASE 9; CASPASES; CELL LINE, TUMOR; ENZYME ACTIVATION; ENZYME INHIBITORS; FEMALE; HUMANS; MEMBRANE GLYCOPROTEINS; NF-KAPPA B; PROTEIN KINASE C-DELTA; RECOMBINANT PROTEINS; RNA INTERFERENCE; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 27144436871     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20535     Document Type: Article

References (35)

1. Ashkenazi A, Dixit VM. 1998. Death receptors: Signaling and modulation. Science 281:1305-1308.
2. Basu A, Lu D, Sun B, Moor AN, Akkaraju GR, Huang J. 2002. Proteolytic activation of protein kinase C-epsilon by caspase-mediated processing and transduction of antiapoptotic signals. J Biol Chem 277:41850-41856.
3. Brodie C, Blumberg PM. 2003. Regulation of cell apoptosis by protein kinase C delta. Apoptosis 8:19-27.
4. Carpenter L, Cordery D, Biden TJ. 2002. Inhibition of protein kinase C delta protects rat INS-1 cells against interleukin-1beta and streptozotocin-induced apoptosis. Diabetes 51:317-324.
5. Datta R, Kojima H, Yoshida K, Kufe D. 1997. Caspase-3-mediated cleavage of protein kinase C θ in induction of apoptosis. J Biol Chem 272:20317-20320.
6. Earnshaw WC, Martins LM, Kaufmann SH. 1999. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68:383-424.
7. Endo K, Oki E, Biedermann V, Kojima H, Yoshida K, Johannes FJ, Kufe D, Datta R. 2000. Proteolytic cleavage and activation of protein kinase Cμ by caspase-3 in the apoptotic response of cells to 1-β-D- arabinofuranosylcytosine and other genotoxic agents. J Biol Chem 275: 18476-18481.
8. Gauthier ML, Torretto C, Ly J, Francescutti V, O'Day DH. 2003. Protein kinase C alpha negatively regulates cell spreading and motility in MDA-MB-231 human breast cancer cells downstream of epidermal growth factor receptor. Biochem Biophys Res Commun 307:839-846.
9. Griffith TS, Broghammer EL. 2001. Suppression of tumor growth following intralesional therapy with TRAIL recombinant adenovirus. Mol Ther 4:257-266.
10. Gschwendt M, Muller HJ, Kielbasa K, Zang R, Kittstein W, Rincke G, Marks F. 1994. Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 199: 93-98.
11. Harper N, farrow SN, Kaptein A, Cohen GM, Macfarlane M. 2001. Modulation of tumor necrosis factor apoptosis-inducing ligand-induced NF-κB activation by inhibition of apical caspases. J Biol Chem 276:34743-34752.
12. Herr I, Debatin KM. 2001. Cellular stress response and apoptosis in cancer therapy. Blood 98:2603-2614.
13. Hornia A, Lu Z, Sukezane T, Zhong M, Foster DA. 1999. Antagonistic effects of protein kinase C alpha and delta on both transformation and phospholipase D activity mediated by the epidermal growth factor receptor. Mol Cell Biol 19:7672-7680.
14. Hug H, Sarre TF. 1993. Protein kinase C isoenzymes: Divergence in signal transduction? Biochem J 291:329-343.
15. Iwabu A, Smith K, Allen FD, Lauffenburger DA, Wells A. 2004. Epidermal growth factor induces fibroblast contractility and motility via a protein kinase C delta-dependent pathway. J Biol Chem 279(15):14551-14560.
16. Janicke RU, Sprengart ML, Wati MR, Porter AG. 1998. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 273:9357-9360.
17. Karin M. 1999. How NF-kappaB is activated: The role of the IkappaB kinase (IKK) complex. Oncogene 18:6867-6874.
18. Keane MM, Rubinstein Y, Cuello M, Ettenberg SA, Baberjee P, Nau MM, Lipkowitz S. 2000. Inhibition of NF-kappaB activity enhances TRAIL mediated apoptosis in breast cancer cell lines. Breast Cancer Res Treat 64:211-219.
19. Kim YS, Schwabe RF, Qian T, Lemasters JJ, Brenner DA. 2002. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells. Hepatol 36:1498-1508.
20. Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ, Ashkenazi A. 2000. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12:611-620.
21. Lee YJ, Froelich CJ, Fujita N, Tsuruo T, Kim JH. 2004. Reconstitution of caspase-3 confers low glucose-enhanced tumor necrosis factor-related apoptosis-inducing ligand cytotoxicity and Akt cleavge. Clin Cancer Res 10:1894-1900.
22. Liu YX, Zhu X, Ma ZY. 1999. Expression, purification of and biological activity of rsTRAIL in E. coli. Chin Sci Bulletin 44:1306-1309.
23. Macfarlane M. 2003. TRAIL-induced signaling and apoptosis. Toxicol Lett 139:89-97.
24. Martelli AM, Sang N, Borgatti P, Capitani S, Neri LM. 1999. Multiple biological responses activated by nuclear protein kinase C. J Cell Biochem 74:499-521.
25. McCracken MA, Miraglia LJ, McKay RA, Strobl JS. 2003. Protein kinase C delta is a prosurvival factor in human breast tumor cell lines. Mol Cancer Ther 2:273-281.
26. Oya M, Ohtsubo M, Takayanagi A, Tachibana M, Shimizu N, Murai M. 2001. Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells. Oncogene 20:3888-3896.
27. Paul CP, Good PD, Winer I, Engelke DR. 2002. Effective expression of small interfering RNA in human cells. Nat Biotechnol 20:505-508.
28. Ravi R, Bedi GC, Engstrom LW, Zeng Q, Mookerjee B, Gelinas C, Fuchs EJ, Bedi A. 2001. Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappaB. Nat Cell Biol 3:409-416.
29. Sarker M, Ruiz-Ruiz C, Robledo G, Lopez-Rivas A. 2002. Stimulation of the mitogen-activated protein kinase pathway antagonizes TRAIL-induced apoptosis downstream of BID cleavage in human breast cancer MCF-7 cells. Oncogene 21:4323-4327.
30. Shigeno M, Nakao K, Ichikawa T, Suzuki K, Kawakami A, Abiru S, Miyazoe S, Nakagawa Y, Ishikawa H, Hamasaki K, Nakata K, Ishii N, Eguch Ki. 2003. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation. Oncogene 22:1653-1662.
31. Singh TR, Shankar S, Chen X, Asim M, Srivastava RK. 2003. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo. Cancer Res 63:5390-5400.
32. Thomas RP, Farrow BJ, Kim S, May MJ, Hellmich MR, Evers BM. 2002. Selective targeting of the nuclear factor kappa B pathway enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated pancreatic cancer cell death. Surgery 132:127-134.
33. Tillman DM, Izeradjene K, Szucs KS, Douglas L, Houghton JA. 2003. Rottlerin sensitizes colon carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via uncoupling of the mitochondria independent of protein kinase C. Cancer Res 63:5118-5125.
34. Walczak H, Krammer PH. 2000. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp Cell Res 256:58-66.
35. Zhang JD, Liu YX, Liu SL, Zheng DX. 2004. The molecular mechanism of different sensitivity of breast cancer cell lines to TRAIL. Chin Sci Bulletin 49:1737-1742.